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Abstracts / Urological Science 26 (2015) S1eS25 S13there were at least 600 papers investigating the contribution of individual
genomic variations to bladder cancer (26-30), while few to UTUC (7, 31,
32). Following the rule of molecular central dogma, the single nucleotide
variations on COX-2 among people may determine their differential
expression of COX-2 and personal susceptibility to cancers. The supporting
data comes from that COX-2 is often undetectable in normal tissues,
whereas overexpression of COX-2 has been observed in neoplastic cells of
canine (33) and human RCC (34-36). In our previous report, COX-2 was
found to be up-regulated in both stromal and tumor cells of more than half
of the UTUC patients and the positive expression of COX-2 in stromal cells
may be a biomarker for UTUC-speciﬁc death and recurrence (10). However,
the contribution of COX-2 genotypes to UTUC has never been studied. In
this study, the genotypes of COX-2 of 218 UTUC patients together with 580
controls (Table III) were examined. Statistically, the distributions of COX-2
genotypes for G-765C and intron 5 were differentially distributed among
the UTUC and healthy control groups (Table III). In addition, the allelic
frequencies of the two polymorphisms were also differentially distributed
between the two groups (Table IV). The results showed that the G allele of
G-765C and A allele of intron 5 were associated with higher risk for UTUC
and the haplotype analysis suggested that individuals with GG/AT and CG/
TT haplotypes at G-765C/intron 5 were at altered risk of UTUC before and
after adjusting of gender and age (Table V). UTUC is not a common cancer
in Taiwan and the world, which may be one of the limitation for genomic
study of UTUC. Compared with previous ﬁnding, we have enlarged the
sample size from 56 cases and 436 controls in 2011 (37) to 218 cases and
580 controls (Table II). The strengthened sample size and the same trend of
signiﬁcant genotype distribution after age and gender adjustments high-
lighted the value, accuracy and reliability of the overall ﬁndings (Table V).
This is the ﬁrst UTUC genomic study showing COX-2 G-765C and intron 5
genotypes were associated with UTUC risk. The G allele of Cox-2 G-765C and
A allele of COX-2 intron 5 were genomic risk factors and may serve as early
screening and prediction biomarkers for UTUC in Taiwan and all over the
world.
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Purpose: Urothelial carcinoma (UC) is common in urinary bladder (UB)
and upper urinary tract (UT). It represents a heterogeneous disease with
high morbidity and mortality. Tumor invasion and progression are a
multifactorial process promoted by microenvironmental changes that
include overexpression of matrix metalloproteinases (MMPs). Through
data mining from a published transcirptomic database of UBUCs
(GSE32894), MMP11 was identiﬁed as the most signiﬁcant gene showing
stepwise upregulation among those associated with the regulation of
metalloendopeptidase activity. We therefore analyze MMP11 protein
expression and its association with clinicopathological factors and sur-
vivals in our well-characterized cohort of UC.
Materials andMethods: Immunohistochemistry evaluated by usingH-score
was used to determine MMP11 protein expression in 295 UBUCs and 340
UTUCs, respectively. The medical records of these patients were reviewed
retrospectively. The MMP11 expression status was further correlated with
clinicopathological features as well as disease-speciﬁc survival (DSS) and
metastasis-free survival (MeFS). Univariate and multivariate statistical ana-
lyses were performed to evaluate the prognostic predictors.Results: MMP11 protein overexpression was signiﬁcantly associated with
advanced pT status (UTUC, p<0.001; UBUC, p<0.001), nodal metastasis
(UTUC, p<0.001; UBUC, p ¼ 0.012), vascular invasion (UTUC, p<0.001;
UBUC, p<0.001) and perineural invasion (UTUC, p ¼ 0.002; UBUC,
p¼ 0.006) in both groups of UC. MMP11 overexpression not only predicted
worse DSS (UTUC, p<0.0001; UBUC, p<0.0001) and MeFS (UTUC,
p<0.0001; UBUC, p<0.0001) at univariate analysis, but implicated inferior
DSS (UTUC, p¼ 0.005; UBUC, p¼ 0.010) andMeFS (UTUC, p¼ 0.018; UBUC,
p ¼ 0.026) in multivariate analysis.
Conclusion: MMP11 overexpression is associated with more aggressive
tumor phenotype and poor prognosis for both patients with UTUC and
UBUC, suggesting it may serve as a potential prognostic and a novel
therapeutic target of UC.
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Purpose: Galactin-1 plays an important role in oncogenic processes. In
several literatures, it has been studied that Galactin-1 is highly related to
some cancers, including hepatocellular carcinoma and breast cancer. In our
present study, we try to clarify the relationship between Galactin-1 over-
expression and prognosis of urinary bladder urothelial carcinoma (UC).
Materials and Methods: We reviewed 185 patients who had bladder UC
and received transurethral resection of bladder tumor. The spacemen was
re-examed by pathologist and further survey about cytoplasmic galactin-1
immunoexpression was performed. Then we correlate the laboratory data
to clinical disease prognosis under statistical analyses.
Results: Positive galectin-1 immunoexpression in tumor signiﬁcantly links
with increment of pT status (p ¼ 0.0295) as well as histological grade
(p ¼ 0.037), the presence of vascular invasion (p ¼ 0.0287), nodal status
(p ¼ 0.0012), high mitotic activity (p ¼ 0.0015) and tumor necrosis
(p ¼ 0.0246). Galectin-1 over-expression in tumor cell predicts the dis-
ease-speciﬁc survival in univariate (P ¼ 0.0002) and multivariate analysis
(P ¼ 0.03, HR ¼ 2.438). Besides, gene of galactine-1 (as LGALS1 gene)
ampliﬁcation is also linked to disease-speciﬁc survival rate (P ¼ 0.0006).
Conclusion: Galectin-1 over-expression is an adverse factor to predict the
prognosis of urinary bladder UC. It may help us about clinical decision
making and outcome prediction. Further relationship between urinary
bladder UC and galactin-1 can be studied on the base of this present study.
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Purpose: Cancer cells adapt to the stress resulting from accelerated cells
growth, lack of nutrients or challenges of anti-cancer drugs by activation of
the autophagy pathway. We demonstrated that human bladder cancer cells
exhibit high level of basal autophagy in our previous studies. We therefore
hypothesize that autophagy inhibitors such as chloroquine (CQ) and
hydroxychloroquine (HCQ) that inhibits autophagosome functionwill result
in cancer cell death by induction of apoptosis in human bladder cancer cells.
Materials and Methods: Human Immortalized uroepithelial cell, SV-Huc-
1; human bladder cancer cells including: transitional cell carcinoma (TCC)
grade I, RT-4; TCC grade II, 5637; TCC grade III, T24; human prostate cancer
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study. Inhibition of basal autophagy was achieved using CQ, HCQ and
Baﬁlomycin A1 (Baf A1) in multiple human bladder cancer cell lines. Cell
viability was assessed byWST-1 assay.Western blot detection of LC3-II was
performed to monitor autophagy, while detection of caspase 3/7 activities
and DNA fragmentationwere conducted to investigate apoptotic induction
in treated cells. The disruption of mitochondria membrane potential
(MMP), the generation of reactive oxygen species (ROS) and lysosome
permeability were accessed by JC-1, H2DCFDA staining and IF detection of
cathepsin D and E, respectively, in CQ- and HCQ-treated cells.
Results: Changes in LC3 ﬂux, monitored by Western blot and IF, indicated
inhibition of autophagy at the level of the autophagosome by CQ and HCQ.
Both two autophagy inhibitors induced cytotoxicity in multiple human
bladder cell lines in time- and dose-dependent manner especially in
advanced cancer cell lines. CQ and HCQ also signiﬁcantly impacted the
clonogenic formation of bladder cancer cells. However, the inhibition of
cell viability was only observed in bladder cancer cell lines but not in SV-
Huc-1, PC3 and MCF-7 cells that reported to be with low basal autophagy
activity. Induction of apoptosis was found in cells treated with CQ and
HCQ. We cannot detected the disruption of mitochondria membrane po-
tential nor the generation of reactive oxygen species in CQ- or HCQ-treated
cells. Translocation of cathepsin B in CQ-treated cells suggesting the
change of lysosome permeability that leads to the blockage of autophagy
and increasing apoptotic cell death by these agents.
Conclusion: Targeting autophagy with CQ or HCQ may be an effective
cancer therapy in human bladder cancer.
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Purpose: Benzyl isothiocyanate (BITC) is contained in cruciferous plants
which are part of the human diet, and has been shown to induce apoptosis
in varies cancer cell lines including human bladder cancer cells. In our
previous work, we showed that BITC induces protective autophagy via
inhibition of mTOR signaling pathway in prostate cancer cells. And the
induced apoptosis and autophagy in human prostate cancer cells were
mediated by BITC-induced ROS generation. Here we investigated weather
inhibition of autophagy enhances apoptosis in human bladder cancer cells
as a novel therapeutic strategy.
Materials and Methods: Human bladder cancer cell lines including
grade II, 5637, and grad III, T24, were used in this study. We also included
mouse bladder cancer cell line, MBT2, for the development of orthotopic
mice bladder cancer model for further study. Baﬁlomycin A1 (Baf A1) and
chloroquine (CQ) were used as autophagy inhibitors. Cell viability in
BITC-treated cells with or without the pretreatment of autophagy in-
hibitors were measured by WST-1 reagent. Detection of autophagy was
conducted by measuring the LC3-II processing and the accumulation of
p62 by Western blotting and immunoﬂuorescent staining of these
marker protein. Detection of apoptosis was performed by the monitored
the caspase 3/7 activity, Western blot of cleavage caspase3 and cell
ﬂowcytometry of DNA fragmentation in treated cells. Detection of
autophagy was conducted by measuring the LC3-II processing and the
accumulation of p62.
Results: Exposure of 5637, T24 and MBT2 cells to pharmacologic concen-
trations of BITC resulted in the decrease of cell viability and autophagy
induction. Although inhibition of basal autophagy by Baf A1 or CQ alone
caused cell viability loss in these bladder cancer cell lines, pre-treatment of
Baf A1 or CQ to inhibit BITC-induced autophagy further enhanced the in-
hibition of cell growth. Enhanced apoptosis judged by the increased cas-
pase 3/7 activity, increased amount of cleaved caspase 3 and elevated level
of DNA fragmentation in BITC-treated cell with Baf A1 or CQ pretreatment
suggesting inhibition of autophagy signiﬁcantly potentiates the anti-can-
cer effect of BITC in human bladder cancer cells.Conclusion: This is the ﬁrst study showed that inhibition of autophagy
induced by BITC markedly enhance apoptosis in human and mouse
bladder cancer cells. We are currently using orthotopic mice bladder
cancer model to translate our results from in vitro to in vivo studies. Our
data may be beneﬁcial for further development of novel therapeutic
strategies against bladder cancer.
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Purpose: The identiﬁcation of potential tumor markers will help improve
therapeutic planning and patient management. Thrombomodulin (TM) is a
sensitive urothelial marker. TM was reported to be one of the endogenous
anti-metastatic factors and has diagnostic and prognostic values for the
progression of carcinoma. In the present study, we examine the role of TM
in bladder cancer.
Materials and Methods:We studied the role of TM in tumor behavior and
related signaling pathways in vitro using the human bladder cancer cell
lines HT1376, HT1197, J82 and T24, and in vivo using animal models. We
also selected clinical specimens from 100 patients with bladder cancer for
immunohistochemical staining to evaluate the predictive capacity of TM in
tumor invasiveness.
Results: The data revealed that positive immunoreactivity for TM was
inversely correlated with clinical stage and DNA methyltransferase 1
immunoreactivity. Decreased TM expression could predict the aggressive
tumor growth and advanced clinical stage in bladder cancer.When TMwas
inhibited, tumor growth rate and invasion ability were augmented in vitro
and in vivo. The underlying changes included increased cell proliferation,
enhanced epithelial-mesenchymal transition (EMT) and angiogenesis.
Moreover, inhibition of NF-kB activation signiﬁcantly increased TM
expression and attenuated tumor aggressiveness in bladder cancer.
Conclusion: TM plays an important role in bladder cancer tumor aggres-
siveness in vitro and in vivo and is a clinically signiﬁcant predictor that
may represent a suitable therapeutic target for bladder cancer.Podium-8
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Purpose: To investigate the prognostic factors for bladder recurrence after
radical nephroureterectomy (RNU) in patients with upper urinary tract
urothelial carcinoma (UUT-UC)
Materials and Methods: From 1994 to 2012, 695 patients with UUT-UC
treated with RNU were enrolled in National Taiwan University Medical
Center. Among them, 532 patients with no prior bladder UC histories were
recruited for analysis. We assessed the impact of potentially prognostic
factors on bladder recurrence after RNU.
Results: The median follow-up period was 47.8 months. In the Cox model,
ureteral involvement and diabetes mellitus (DM) were signiﬁcantly asso-
ciated with a higher bladder recurrence rate in the multivariate analysis
(hazard ratio [HR]: 1.838; p¼ 0.003 and HR: 1.821; p¼ 0.010, respectively).
In the Kaplan-Meier analysis, DM patients with concomitant ureteral UC
